Neprilysin

Neprilysin

Neprilysin (NEP) is a type II membrane metalloendopeptidase composed of ∼750 residues with an active site containing a zinc-binding motif (HEXXH) at the extracellular carboxyl terminal domain.Neprilysin has the ability to break down both the oligomeric and monomeric forms of the A peptide. The main A-peptide-degrading enzyme in the brain is called neprilysin, and both aging and Alzheimer's disease (AD) cause neprilysin to become inactive and down-regulated.

Neutral endopeptidase neprilysin increases the bioavailability of substance P, bradykinin, and natriuretic peptides, which has natriuretic, vasodilatory, and anti-proliferative effects.

Neprilysin related products

Structure Cat No. Product Name CAS No. Product Description
V4540 Sacubitril hemicalcium 1369773-39-6 Sacubitril hemicalcium (also known as AHU377; AHU-377; Entresto), thehemicalcium salt of Sacubitril which is a component of the heart failure medicine LCZ696 (sacubitril/valsartan), is a novel and potentNEP (neutral endopeptidase 24.11)inhibitor with anIC50of 5 nM.
V4542 Sacubitrilat (LBQ-657) 149709-44-4 Sacubitrilat (formerly known as LBQ-657; LBQ657) is the activated form of Sacubitril (AHU-377; AHU-377; Entresto), which is a novel and potentNEP (neutral endopeptidase 24.11)inhibitor used in combination with valsartan (LCZ696) for treating heart failure.
Contact Us Back to top